Oticon More vs Vivtone Xpure Hearing Aid

The Oticon More is a premium prescription behind-the-ear hearing aid that earns an A grade with a SoundScore of 4.6/5 in our lab testing, placing it in the top 23% of the 39 prescription hearing aids we've evaluated. Currently available at $4,598, this 2021 release has earned our Expert's Choice Award in both 2023 and 2024. In our testing, the Oticon More demonstrates strong speech clarity performance. Speech in quiet scores 4.0/5, which is 0.65 points above the category average—a meaningful advantage for everyday conversation. Speech in noise measures 2.7/5, which is 0.60 points above the category average, though the absolute score reflects the inherent challenge all hearing aids face in noisy environments. Own-voice comfort is solid at 3.1/5, sitting 0.40 points above average. The device does show one notable weakness: feedback handling scores 3.5/5, which is 1.22 points below the category average of 4.72/5. While this is still a solid score in absolute terms, competing devices in this price range generally perform better in this area. Music streaming is solid at 3.0/5, slightly above the category average. The Oticon More offers flexibility with both rechargeable and disposable battery options, plus streaming compatibility with both iPhone and Android devices including hands-free calling. For those considering alternatives, newer models like the Oticon Intent and Oticon Real score higher in our testing at similar price points. The Oticon More remains a capable choice for listeners who prioritize speech clarity and want a well-established platform with proven performance.

The Vivtone Xpure is a behind-the-ear OTC hearing aid priced at $549, earning a B grade with a SoundScore of 3.1/5 in HearAdvisor's lab testing. This places it in the lower tier of the OTC category, ranking #57 of 65 devices tested. The Xpure demonstrates a notably uneven performance profile. Its standout strength is music streaming, scoring an excellent 4.4/5—a remarkable 2.48 points above the category average. This makes it one of the better choices for users who prioritize audio entertainment through their hearing aids. Speech in quiet performs just slightly above category average at 2.9/5, though this remains mixed in absolute terms. However, the device shows significant weaknesses in several areas. Own-voice comfort scores a low 0.8/5, falling 1.71 points below the category average—a notable concern for users sensitive to how their own voice sounds. Speech in noise at 1.2/5 sits below the category average, and feedback handling, while solid at 3.3/5, still falls 1.24 points below what typical OTC devices achieve. The Xpure improves meaningfully with professional tuning, jumping from a normalized Initial Score of 3.0/5 to a Tuned Score of 3.5/5. Shoppers prioritizing music streaming may find value here, but those seeking balanced speech performance or natural own-voice quality should consider alternatives like the Linner Nova Earbud or Nuheara IQBuds Max, which offer higher overall scores at lower prices.